Skip to main content
Erschienen in: Clinical and Experimental Medicine 3/2016

17.06.2015 | Original Article

Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1

Erschienen in: Clinical and Experimental Medicine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Paired box gene1 (PAX1) is essential for normal chordate development and has been recently characterised to be a tumour suppressor gene which is frequently hypermethylated in different cancer types. We investigated the reactivation of PAX1 using curcumin and resveratrol in HeLa, SiHa and Caski cell lines and role of hypermethylation in 39 CpG sites of PAX1 promoter from −6 to −286 region in regulating its expression. Curcumin in HeLa and SiHa cells and resveratrol in Caski cells caused significant (P < 0.01) reactivation of PAX1 expression as shown by qRT PCR, but reversal of promoter hypermethylation was not observed across the three cell lines. Interestingly, even positive control 5-aza-2′-deoxycytidine was not found to be effective to cause demethylation of CpG sites under consideration suggesting the promoter region to be resistant towards hypomethylating effects as shown by bisulphite sequencing. However, a striking correlation between PAX1 reactivation and Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) downregulation after treatment with curcumin and resveratrol in HeLa, SiHa and Caski cell lines was observed which was further confirmed after transient silencing of UHRF1 expression. PAX1 reexpression was also obtained in Caski and SiHa cell lines after treatment with sodium butyrate, a histone deacetylase inhibitor, suggesting that PAX1 reactivation by curcumin and resveratrol may be due to their effect on histone deacetylase mediated through downregulation of UHRF1 which can regulate both DNA methylation and histone acetylation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Guerrero-Preston R, Michailidi C, Marchionni L, et al. Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9:1031–46.CrossRefPubMedPubMedCentral Guerrero-Preston R, Michailidi C, Marchionni L, et al. Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9:1031–46.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Chao TK, Ke FY, Liao YP, Wang HC, Yu CP, Lai HC. Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1(PAX1). Diagn Cytopathol. 2011;41:41–6.CrossRefPubMed Chao TK, Ke FY, Liao YP, Wang HC, Yu CP, Lai HC. Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1(PAX1). Diagn Cytopathol. 2011;41:41–6.CrossRefPubMed
3.
Zurück zum Zitat Takimoto A, Mohri H, Kokubu C, Hiraki Y, Shukunami C. Pax1 acts as a negative regulator of chondrocyte maturation. Exp Cell Res. 2013;319:3128–39.CrossRefPubMed Takimoto A, Mohri H, Kokubu C, Hiraki Y, Shukunami C. Pax1 acts as a negative regulator of chondrocyte maturation. Exp Cell Res. 2013;319:3128–39.CrossRefPubMed
4.
Zurück zum Zitat Peters H, Wilm B, Sakai N, Imai K, Maas R, Balling R. Pax1 and pax9 synergistically regulate vertebral column development. Development. 1999;126:5399–408.PubMed Peters H, Wilm B, Sakai N, Imai K, Maas R, Balling R. Pax1 and pax9 synergistically regulate vertebral column development. Development. 1999;126:5399–408.PubMed
5.
Zurück zum Zitat Singh V, Sharma P, Capalash N. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer. Curr Cancer Drug Targets. 2013;13:379–99.CrossRefPubMed Singh V, Sharma P, Capalash N. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer. Curr Cancer Drug Targets. 2013;13:379–99.CrossRefPubMed
6.
Zurück zum Zitat Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer. 2009;124:387–93.CrossRefPubMed Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer. 2009;124:387–93.CrossRefPubMed
7.
Zurück zum Zitat Huang YK, Peng BY, Wu CY, Su CT, Wang HC, Lai HC. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma. Clin Oral Investig. 2014;18:801–8.CrossRefPubMed Huang YK, Peng BY, Wu CY, Su CT, Wang HC, Lai HC. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma. Clin Oral Investig. 2014;18:801–8.CrossRefPubMed
8.
Zurück zum Zitat Elaine HL, Ng SL, Li JL, et al. Cervical dysplasia: assessing methylation status (methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol. 2010;119:225–31.CrossRef Elaine HL, Ng SL, Li JL, et al. Cervical dysplasia: assessing methylation status (methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol. 2010;119:225–31.CrossRef
9.
Zurück zum Zitat Vasiljević N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecol Oncol. 2014;132:709–14.CrossRefPubMedPubMedCentral Vasiljević N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecol Oncol. 2014;132:709–14.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Chang CC, Huang RL, Wang HC, Liao YP, Yu MH, Lai HC. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma. Int J Gynecol Cancer. 2014;24:201–9.CrossRefPubMed Chang CC, Huang RL, Wang HC, Liao YP, Yu MH, Lai HC. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma. Int J Gynecol Cancer. 2014;24:201–9.CrossRefPubMed
11.
Zurück zum Zitat Lai HC, Ou YC, Chen TC, et al. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study. Cancer Med. 2014;3(4):1062–74.CrossRefPubMedPubMedCentral Lai HC, Ou YC, Chen TC, et al. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study. Cancer Med. 2014;3(4):1062–74.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet. 1994;94:491–6.CrossRefPubMed Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet. 1994;94:491–6.CrossRefPubMed
13.
Zurück zum Zitat Alhosin M, Sharif T, Mousli M, et al. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res. 2011;30:41.CrossRefPubMedPubMedCentral Alhosin M, Sharif T, Mousli M, et al. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res. 2011;30:41.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB. The UHRF family: oncogenes that are druggable targets for cancer therapy in the near future. Pharmacol Ther. 2007;115:419–34.CrossRefPubMed Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB. The UHRF family: oncogenes that are druggable targets for cancer therapy in the near future. Pharmacol Ther. 2007;115:419–34.CrossRefPubMed
15.
Zurück zum Zitat Achour M, Mousli M, Alhosin M, et al. Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. Biochem Biophys Res Commun. 2013;430:208–12.CrossRefPubMed Achour M, Mousli M, Alhosin M, et al. Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. Biochem Biophys Res Commun. 2013;430:208–12.CrossRefPubMed
16.
Zurück zum Zitat Lai HC, Lin YW, Huang TH, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008;123:161–7.CrossRefPubMed Lai HC, Lin YW, Huang TH, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008;123:161–7.CrossRefPubMed
17.
Zurück zum Zitat Zhang Y, Chen FQ, Sun YH, Zhou SY, Li TY, Chen R. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. J Exp Clin Cancer Res. 2011;30:98.CrossRefPubMedPubMedCentral Zhang Y, Chen FQ, Sun YH, Zhou SY, Li TY, Chen R. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. J Exp Clin Cancer Res. 2011;30:98.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Mulder GB, Manley N, Maggio-Price L. Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects and altered expression of Hoxa3 and Pax1. Teratology. 1998;58:263–75.CrossRefPubMed Mulder GB, Manley N, Maggio-Price L. Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects and altered expression of Hoxa3 and Pax1. Teratology. 1998;58:263–75.CrossRefPubMed
19.
Zurück zum Zitat Holland LZ, Holland ND. Expression of amphiHox-1 and amphiPax-1 in amphioxus embryos treated with retinoic acid: insights into evolution and patterning of the chordate nerve cord and pharynx. Development. 1996;122:1829–38.PubMed Holland LZ, Holland ND. Expression of amphiHox-1 and amphiPax-1 in amphioxus embryos treated with retinoic acid: insights into evolution and patterning of the chordate nerve cord and pharynx. Development. 1996;122:1829–38.PubMed
20.
Zurück zum Zitat Stefanska B, Rudnicka K, Bednarek A, Fabianowska-Majewska K. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur J Pharmacol. 2010;638:47–53.CrossRefPubMed Stefanska B, Rudnicka K, Bednarek A, Fabianowska-Majewska K. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur J Pharmacol. 2010;638:47–53.CrossRefPubMed
21.
Zurück zum Zitat Parashar G, Parashar NC, Capalash N. Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line. Mol Cell Biochem. 2012;365:29–35.CrossRefPubMed Parashar G, Parashar NC, Capalash N. Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line. Mol Cell Biochem. 2012;365:29–35.CrossRefPubMed
22.
Zurück zum Zitat Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005;21:4067–8.CrossRefPubMed Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005;21:4067–8.CrossRefPubMed
23.
Zurück zum Zitat Parashar G, Capalash N. Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line. Oncol Lett. 2012;3:1079–82.PubMedPubMedCentral Parashar G, Capalash N. Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line. Oncol Lett. 2012;3:1079–82.PubMedPubMedCentral
25.
Zurück zum Zitat Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res. 2010;70(17):6968–77.CrossRefPubMedPubMedCentral Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res. 2010;70(17):6968–77.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Bronner C, Krifa M, Mousli M. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorigenesis. Biochem Pharmacol. 2013;86:1643–9.CrossRefPubMed Bronner C, Krifa M, Mousli M. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorigenesis. Biochem Pharmacol. 2013;86:1643–9.CrossRefPubMed
27.
Zurück zum Zitat Sharif T, Auger C, Alhosin M, et al. Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redoxsensitive up-regulation of p73 and down-regulation of UHRF1. Eur J Cancer. 2010;46:983–94.CrossRefPubMed Sharif T, Auger C, Alhosin M, et al. Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redoxsensitive up-regulation of p73 and down-regulation of UHRF1. Eur J Cancer. 2010;46:983–94.CrossRefPubMed
28.
Zurück zum Zitat Abusnina A, Keravis T, Yougbaré I, Bronner C, Lugnier C. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol Nutr Food Res. 2011;55:1677–89.CrossRefPubMed Abusnina A, Keravis T, Yougbaré I, Bronner C, Lugnier C. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol Nutr Food Res. 2011;55:1677–89.CrossRefPubMed
29.
Zurück zum Zitat Raynal NJ-M, Si J, Taby RF, et al. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res. 2012;72:1170–81.CrossRefPubMedPubMedCentral Raynal NJ-M, Si J, Taby RF, et al. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res. 2012;72:1170–81.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3:166–79.PubMed Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3:166–79.PubMed
Metadaten
Titel
Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1
Publikationsdatum
17.06.2015
Erschienen in
Clinical and Experimental Medicine / Ausgabe 3/2016
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0366-1

Weitere Artikel der Ausgabe 3/2016

Clinical and Experimental Medicine 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.